Pere Barba, Advanced Therapy Lead at VHIO and Vladimir Galvao, CORE Phase I Investigator at UITM - Caixa Research - VHIO, summarize the session thy chaired at the First VHIO BBVA International Symposium on "Advances in CAR-T cells for hematological malignancies".
Негізгі бет Advances in CAR-T cells for hematological malignancies
Пікірлер